Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1998-7-1
|
| pubmed:abstractText |
To attempt to safely escalate the dose of radiation for patients with intrahepatic cancer, we designed a protocol in which each patient received the maximum possible dose while being subjected to a 10% risk of radiation-induced liver disease (RILD, or radiation hepatitis) based on a normal tissue complication probability (NTCP) model. We had two hypotheses: H1; with this approach, we could safely deliver higher doses of radiation than we would have prescribed based on our previous protocol, and H2; the model would predict the observed complication probability (10%).
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0732-183X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
16
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2246-52
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:9626227-Antimetabolites, Antineoplastic,
pubmed-meshheading:9626227-Combined Modality Therapy,
pubmed-meshheading:9626227-Floxuridine,
pubmed-meshheading:9626227-Humans,
pubmed-meshheading:9626227-Liver Neoplasms,
pubmed-meshheading:9626227-Models, Statistical,
pubmed-meshheading:9626227-Radiotherapy
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.
|
| pubmed:affiliation |
Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor 48109-0010, USA. mcginn@umich.edu
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|